Skip to main content

GX CG5 (Lamivudine 100 mg)

Pill with imprint GX CG5 is Brown, Capsule-shape and has been identified as Lamivudine 100 mg. It is supplied by Prasco Laboratories.

Lamivudine is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GX CG5

Lamivudine 100 mg GX CG5
Lamivudine 100 mg GX CG5
Lamivudine 100 mg GX CG5


100 mg
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Prasco Laboratories
Inactive Ingredients
hypromelloses, polyethylene glycol, magnesium stearate, microcrystalline cellulose, polysorbate 80, ferric oxide red, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
66993-0478 Prasco Laboratories
00173-0662 GlaxoSmithKline

Get help with Imprint Code FAQs.

Related images for "GX CG5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.